查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2130780

穿戴式血糖監測儀市場分析及預測（至2035年）：類型、產品類型、服務、技術、組件、應用、設備、最終用戶、功能、解決方案

Wearable Glucose Monitors Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Device, End User, Functionality, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球穿戴式血糖監測儀市場預計將從2025年的43億美元成長到2035年的102億美元，複合年成長率（CAGR）為9.9%。推動這一市場成長的主要因素是糖尿病患者人數的龐大且持續成長。根據國際糖尿病聯盟（IDF）估計，到2024年，全球20至79歲的成年人中將有約5.89億人患有糖尿病，為血糖值監測技術創造了廣泛的目標人口。美國疾病管制與預防中心（CDC）報告稱，超過4,000萬美國人患有糖尿病，這推動了對持續疾病管理工具的需求。此外，市場應用趨勢正朝著互聯監測、遠端資料共用、智慧型手機平台和自動化分析的方向發展。感測器可用性的提高、佩戴舒適度的提升、保險報銷機制的改進以及與數位健康生態系統的整合都在促進市場需求，而消費者健康應用程式則擴大了潛在用戶群。

該服務包括遠端監測、數據分析、諮詢和培訓，旨在支援穿戴式血糖監測系統的有效部署和結果解讀。遠端監測使臨床醫生和看護者能夠了解血糖值的變化趨勢和乾預需求，而數據分析則將連續測量數據轉化為具體的趨勢、警報和個人化見解。諮詢服務可協助使用者和醫療保健專業人員選擇設備、解讀結果並最佳化治療方案，而培訓則有助於改善感測器放置、設備操作、資料共用和治療依從性。與遠端醫療平台和數位療法的整合進一步擴展了該服務的功能。這一成長得益於互聯醫療模式的日益普及、對分散式監測和個人化管理的需求，以及數位科技驅動的慢性病管理計畫的蓬勃發展。

市場區隔
種類 連續血糖監測儀、瞬感血糖監測儀及其他
產品 腕帶、貼片、智慧型手錶等等
服務 數據管理、諮詢及其他服務。
科技 非侵入性、微創性、其他
成分 感測器、發送器、接收器及其他
目的 糖尿病管理、運動與健身、遠端患者監護等。
裝置 獨立設備、整合設備及其他
最終用戶 醫院、居家醫療機構、診所及其他
功能 即時監控、歷史數據分析、警報和通知等。
解決方案 軟體平台、行動應用程式及其他

主要應用領域包括糖尿病管理、健身追蹤和臨床研究，其中糖尿病管理是核心應用領域。穿戴式監測設備能夠持續可視化血糖值，從而輔助治療決策、識別血糖值波動並促進生活方式調整。在健身應用方面，代謝資訊正被擴大用於評估營養狀況、運動反應、恢復情況以及製定個人化健康策略，使其應用範圍超越了已確診的糖尿病患者。在臨床研究方面，縱向血糖資料集正被用於研究代謝紊亂、治療方法、營養狀況和藥物反應。感測器精度的提高、智慧型手機連接性、雲端分析以及消費者對個人化健康管理日益成長的興趣，都在推動這一領域的擴展。同時，在研究應用方面，數據驅動型調查方法的日益普及也促進了其發展。

區域概覽

北美憑藉其完善的糖尿病護理基礎設施、先進的數位健康生態系統以及持續血糖監測技術的廣泛應用，在穿戴式血糖監測領域保持著強勁的地位。美國擁有大規模的糖尿病確診患者和高風險族群、專業的醫療保健網路、遠端醫療以及完善的醫療設備分銷管道，是該領域的主要需求市場。領先的科技和醫療保健公司正致力於建立一個涵蓋感測器、軟體、數據平台和互聯醫療的成熟產業生態系統。美國食品藥物管理局(FDA) 的法律規範支持技術的檢驗和市場發展，而不斷完善的保險報銷機制以及醫療服務提供者日益成長的接受度，則促進了穿戴式血糖監測技術更廣泛地融入日常糖尿病管理和遠端醫療中。

在亞太地區，隨著糖尿病盛行率的上升、醫療數位化、消費者健康意識的增強以及互聯醫療技術在主要經濟體中的普及，這些技術的應用正在不斷擴展。中國、日本、韓國、印度和澳洲正在加強其數位醫療基礎設施建設，為穿戴式血糖監測解決方案創造了機會。對醫療設備製造、本地技術研發、遠端醫療平台和醫療互聯互通的投資正在推動該地區的成長。國際製造商正在拓展銷售合作夥伴關係並擴大市場佔有率，而當地企業則在開發適用於不同醫療環境的、經濟高效的監測技術。人們對預防醫學的日益重視以及對個人化代謝監測需求的成長，預計將推動全部區域市場的持續發展。

主要趨勢和促進因素

連網血糖監測重新定義了個人化代謝健康的概念：

穿戴式血糖監測與數位健康生態系統的融合正在重塑市場格局，連網感測器與智慧型手機、雲端平台、遠端醫療服務、人工智慧和個人化健康應用程式的整合度日益提高。先進的分析技術能夠解讀血糖值波動，而不僅僅是孤立的讀數，從而提供預測性洞察和個人化建議。製造商也致力於研發更小巧的感測器、更長的佩戴時間、更佳的連接性能以及更人性化的介面，以提高用戶依從性，並擴大其在預防醫學和健身領域的應用。

對持續性和個人化糖尿病管理的需求日益成長：

對持續性和個人化糖尿病管理的需求日益成長，推動了穿戴式血糖監測儀的需求。持續監測血糖值血糖值使用戶和醫療專業人員能夠識別血糖波動，評估患者對飲食和運動的反應，並支持更明智的治療決策。遠端患者監護和虛擬護理的擴展進一步提升了互聯血糖數據的價值。糖尿病盛行率的上升、醫療機構對主動疾病管理的日益重視以及消費者對穿戴式健康技術的接受度不斷提高，都促進了穿戴式裝置在臨床和居家照護環境中的應用。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 持續血糖監測
    • 瞬時血糖監測儀
    • 其他
  • 市場規模及預測：依產品分類
    • 腕帶
    • 修補
    • 智慧型手錶
    • 其他
  • 市場規模及預測：依服務分類
    • 資料管理
    • 諮詢
    • 其他
  • 市場規模及預測：依技術分類
    • 非侵入性
    • 微創
    • 其他
  • 市場規模及預測：依組件分類
    • 感應器
    • 發送器
    • 接收器
    • 其他
  • 市場規模及預測：依應用領域分類
    • 糖尿病管理
    • 運動與健身
    • 遠端患者監護
    • 其他
  • 市場規模及預測：依設備分類
    • 獨立設備
    • 整合設備
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 居家照護環境
    • 診所
    • 其他
  • 市場規模及預測：功能
    • 即時監控
    • 對過去數據的分析
    • 警報和通知
    • 其他
  • 市場規模及預測：按解決方案分類
    • 軟體平台
    • 行動應用
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Abbott Laboratories
  • Dexcom
  • Medtronic
  • Senseonics
  • Roche
  • Ascensia Diabetes Care
  • GlySens
  • Nemaura Medical
  • Biolinq
  • POCTech
  • Medtrum Technologies
  • A. Menarini Diagnostics
  • LifeScan
  • Sanofi
  • Novo Nordisk
  • Insulet Corporation
  • Ypsomed
  • Tandem Diabetes Care
  • GlucoTrack
  • DarioHealth

第9章 關於我們

簡介目錄
Product Code: GIS32788

The global Wearable Glucose Monitors Market is projected to grow from $4.3 billion in 2025 to $10.2 billion by 2035, at a compound annual growth rate (CAGR) of 9.9%. The market is supported by a substantial and expanding diabetes population. The International Diabetes Federation estimates that approximately 589 million adults aged 2079 were living with diabetes globally in 2024, creating a broad addressable population for glucose-monitoring technologies. The U.S. Centers for Disease Control and Prevention reports that more than 40 million Americans have diabetes, reinforcing demand for continuous disease-management tools. Adoption is also shifting toward connected monitoring, remote data sharing, smartphone-enabled platforms, and automated analytics. Increasing sensor availability, improved wearability, reimbursement developments, and integration with digital health ecosystems are strengthening demand, while consumer wellness applications are widening the potential user base.

Services include remote monitoring, data analytics, consultation, and training that support the effective deployment and interpretation of wearable glucose-monitoring systems. Remote monitoring enables clinicians and caregivers to review glucose patterns and intervention needs, while data analytics converts continuous readings into actionable trends, alerts, and personalized insights. Consultation services assist users and healthcare providers with device selection, interpretation, and therapy optimization, whereas training improves sensor placement, device operation, data sharing, and adherence. Integration with telehealth platforms and digital therapeutics is expanding service capabilities. Growth is supported by increasing connected-care models, decentralized monitoring, demand for personalized management, and broader use of digitally enabled chronic disease programs.

Market Segmentation
TypeContinuous Glucose Monitors, Flash Glucose Monitors, Others
ProductWristbands, Patches, Smartwatches, Others
ServicesData Management, Consultation, Others
TechnologyNon-invasive, Minimally Invasive, Others
ComponentSensors, Transmitters, Receivers, Others
ApplicationDiabetes Management, Sports & Fitness, Remote Patient Monitoring, Others
DeviceStandalone Devices, Integrated Devices, Others
End UserHospitals, Homecare Settings, Clinics, Others
FunctionalityReal-time Monitoring, Historical Data Analysis, Alerts & Notifications, Others
SolutionsSoftware Platforms, Mobile Applications, Others

Applications include diabetes management, fitness tracking, and clinical research, with diabetes management representing the core utilization area. Wearable monitors provide continuous glucose visibility, support treatment decisions, identify glucose variability, and facilitate lifestyle adjustments. Fitness applications increasingly use metabolic information to evaluate nutrition, exercise responses, recovery, and personalized wellness strategies, broadening adoption beyond diagnosed diabetes. Clinical research applications leverage longitudinal glucose datasets for studying metabolic disorders, therapies, nutrition, and drug responses. Expansion is supported by improving sensor accuracy, smartphone connectivity, cloud analytics, and growing consumer interest in personalized health, while research applications benefit from increasingly data-driven study methodologies.

Geographical Overview

North America maintains a strong position in wearable glucose monitoring due to established diabetes-care infrastructure, advanced digital-health ecosystems, and extensive availability of continuous glucose monitoring technologies. The United States represents the principal demand base, supported by a large diagnosed and at-risk population, specialist healthcare networks, telehealth adoption, and sophisticated medical-device distribution channels. Major technology and healthcare companies contribute to an established industrial ecosystem spanning sensors, software, data platforms, and connected care. Regulatory oversight from the U.S. Food and Drug Administration supports technology validation and market development, while evolving reimbursement and healthcare-provider adoption encourage broader integration into routine diabetes management and remote care.

Asia Pacific is seeing expanding adoption as diabetes prevalence, healthcare digitization, consumer health awareness, and access to connected medical technologies increase across major economies. China, Japan, South Korea, India, and Australia are strengthening digital-health infrastructure and creating opportunities for wearable glucose-monitoring solutions. Investments in medical-device manufacturing, local technology development, telemedicine platforms, and healthcare connectivity are supporting regional expansion. International manufacturers are increasing distribution partnerships and market presence, while domestic companies are developing cost-conscious monitoring technologies suited to diverse healthcare settings. Rising preventive-health awareness and demand for personalized metabolic monitoring are expected to support sustained market development across the region.

Key Trends and Drivers

Connected Glucose Monitoring Redefines Personalized Metabolic Health:

Integration of wearable glucose monitoring with digital health ecosystems is reshaping the market, with connected sensors increasingly linked to smartphones, cloud platforms, telehealth services, artificial intelligence, and personalized wellness applications. Advanced analytics are enabling interpretation of glucose variability rather than simple point measurements, supporting predictive insights and individualized recommendations. Manufacturers are also emphasizing smaller sensors, longer wear periods, improved connectivity, and more user-friendly interfaces to increase adherence and extend adoption into preventive health and fitness applications.

Rising Demand for Continuous and Personalized Diabetes Management:

The growing need for continuous and personalized diabetes management is driving demand for wearable glucose monitors. Continuous access to glucose information enables users and healthcare professionals to identify fluctuations, evaluate responses to food and physical activity, and support more informed treatment decisions. Expansion of remote patient monitoring and virtual care is further increasing the value of connected glucose data. Rising diabetes prevalence, healthcare emphasis on proactive disease management, and increasing consumer acceptance of wearable health technologies are collectively strengthening adoption across clinical and home-care environments.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Continuous Glucose Monitors
    • 4.1.2 Flash Glucose Monitors
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Wristbands
    • 4.2.2 Patches
    • 4.2.3 Smartwatches
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Data Management
    • 4.3.2 Consultation
    • 4.3.3 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Non-invasive
    • 4.4.2 Minimally Invasive
    • 4.4.3 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Transmitters
    • 4.5.3 Receivers
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Diabetes Management
    • 4.6.2 Sports & Fitness
    • 4.6.3 Remote Patient Monitoring
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Standalone Devices
    • 4.7.2 Integrated Devices
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Homecare Settings
    • 4.8.3 Clinics
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Real-time Monitoring
    • 4.9.2 Historical Data Analysis
    • 4.9.3 Alerts & Notifications
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Software Platforms
    • 4.10.2 Mobile Applications
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Device
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Device
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Device
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Device
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Device
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Device
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Device
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Device
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Device
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Device
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Device
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Device
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Device
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Device
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Device
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Device
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Device
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Device
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Device
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Device
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Device
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Device
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Device
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Device
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dexcom
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Medtronic
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Senseonics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Roche
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Ascensia Diabetes Care
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 GlySens
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Nemaura Medical
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Biolinq
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 POCTech
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Medtrum Technologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 A. Menarini Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 LifeScan
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Sanofi
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Novo Nordisk
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Insulet Corporation
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ypsomed
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Tandem Diabetes Care
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 GlucoTrack
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 DarioHealth
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us